These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Hyperprolactinaemia: its physiology and investigation. Judd SJ; Lazarus L; Compton P Med J Aust; 1976 Jul; 2(1):23-5. PubMed ID: 988468 [TBL] [Abstract][Full Text] [Related]
24. Pulsatile GnRH therapy--an alternative successful therapy for induction of ovulation in infertile normo- and hyperprolactinaemic amenorrhoeic women with pituitary tumours. Bergh T; Skarin G; Nillius SJ; Wide L Acta Endocrinol (Copenh); 1985 Dec; 110(4):440-4. PubMed ID: 3911713 [TBL] [Abstract][Full Text] [Related]
25. Conservative management of pituitary prolactinomas; evidence for bromocriptine-induced regression. Hancock KW; Scott JS; Lamb JT; Gibson RM; Chapman C Br J Obstet Gynaecol; 1980 Jun; 87(6):523-9. PubMed ID: 7397087 [TBL] [Abstract][Full Text] [Related]
26. Oestrogen modulation of gonadotrophin and prolactin release in women with anovulation and their responses to clomiphene. Kandeel FR; Butt WR; Rudd BT; Lynch SS; London DR; Edwards RL Clin Endocrinol (Oxf); 1979 Jun; 10(6):619-35. PubMed ID: 383317 [TBL] [Abstract][Full Text] [Related]
27. Bromocriptine treatment of women with suspected pituitary prolactin-secreting microadenomas. Archer DF; Lattanzi DR; Moore EE; Harger JH; Herbert DL Am J Obstet Gynecol; 1982 Jul; 143(6):620-5. PubMed ID: 7201244 [TBL] [Abstract][Full Text] [Related]
28. Clinical response to CB-154 and the pituitary response to thyrotropin-releasing hormone-gonadotropin-releasing hormone in patients with galactorrhea-amenorrhea. March CM; Kletzky OA; Davajan V Fertil Steril; 1977 May; 28(5):521-5. PubMed ID: 404198 [TBL] [Abstract][Full Text] [Related]
29. Restoration of oestrogen positive feedback effect on LH release by bromocriptine in hyperprolactinaemic patients with galactorrhoea-amenorrhoea. Aono T; Miyake A; Yasuda TS; Koike K; Kurachi K Acta Endocrinol (Copenh); 1979 Aug; 91(4):591-600. PubMed ID: 227202 [TBL] [Abstract][Full Text] [Related]
30. Clinical course and outcome of pregnancies in amenorrhoeic women with hyperprolactinaemia and pituitary tumors. Bergh T; Nillius SJ; Wide L Br Med J; 1978 Apr; 1(6117):875-80. PubMed ID: 638504 [TBL] [Abstract][Full Text] [Related]
31. Successful pregnancy after bromocriptine therapy in an anovulatory woman complicated with ovarian hyperstimulation caused by follicle-stimulating hormone-producing plurihormonal pituitary microadenoma. Murata Y; Ando H; Nagasaka T; Takahashi I; Saito K; Fukugaki H; Matsuzawa K; Mizutani S J Clin Endocrinol Metab; 2003 May; 88(5):1988-93. PubMed ID: 12727942 [TBL] [Abstract][Full Text] [Related]
32. Value of luteinizing hormone-releasing hormone testing in bromocriptine treatment of amenorrhea and hyperprolactinemia in patients with pituitary tumors. Lamberts SW; Docter R; De Jong FH; Birkenhäger JC; Kwa HG Fertil Steril; 1978 Mar; 29(3):287-90. PubMed ID: 346383 [TBL] [Abstract][Full Text] [Related]
33. Prolactin-secreting pituitary adenomas in women. II. Menstrual function, pituitary reserves, and prolactin production following microsurgical removal. Keye WR; Chang RJ; Monroe SE; Wilson CB; Jaffe RB Am J Obstet Gynecol; 1979 Jun; 134(4):360-5. PubMed ID: 222148 [TBL] [Abstract][Full Text] [Related]
34. Serum prolactin and ovarian function after discontinuation of drug treatment for hyperprolactinaemia: a study with bromocriptine and metergoline. Mattei AM; Ferrari C; Ragni G; Benco R; Picciotti MC; Rampini P; Caldara R; Crosignani PG Br J Obstet Gynaecol; 1984 Mar; 91(3):244-50. PubMed ID: 6704349 [TBL] [Abstract][Full Text] [Related]
35. Diagnosis and drug therapy of prolactinoma. Ciccarelli E; Camanni F Drugs; 1996 Jun; 51(6):954-65. PubMed ID: 8736617 [TBL] [Abstract][Full Text] [Related]
36. Induction of ovulation in patients with normoprolactinemic amenorrhea by combined therapy with bromocriptine and clomiphene. Koike K; Aono T; Miyake A; Tsutsumi H; Matsumoto K; Kurachi K Fertil Steril; 1981 Feb; 35(2):138-41. PubMed ID: 6781935 [TBL] [Abstract][Full Text] [Related]
37. Rapid regression of pituitary tumours during bromocriptine treatment of women with hyperprolactinaemia. Bergh T; Nillius SJ; Lundberg PO; Moström U; Enoksson P; Ohman L; Wide L Ups J Med Sci; 1982; 87(3):259-67. PubMed ID: 7157557 [TBL] [Abstract][Full Text] [Related]
38. Development of pituitary adenoma in women with hyperprolactinaemia: clinical, endocrine, and radiological characteristics. Pontiroli AE; Falsetti L Br Med J (Clin Res Ed); 1984 Feb; 288(6416):515-8. PubMed ID: 6421360 [TBL] [Abstract][Full Text] [Related]
39. Therapeutic use of bromocriptine in women with amenorrhea-galactorrhea and suspected pituitary microadenoma. Jewelewicz R Adv Biochem Psychopharmacol; 1980; 23():209-15. PubMed ID: 7395612 [No Abstract] [Full Text] [Related]
40. Pituitary function in prolactinoma. Effect of surgery and postoperative bromocriptine therapy. Pelkonen R; Grahne B; Hirvonen E; Karonen SL; Salmi J; Tikkanen M; Valtonen S Clin Endocrinol (Oxf); 1981 Apr; 14(4):335-48. PubMed ID: 7261416 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]